Navigation Links
Renal Advantage and Liberty Dialysis Deal Completed
Date:12/22/2010

FRANKLIN, Tenn. and MERCER ISLAND, Wash., Dec. 22, 2010 /PRNewswire/ -- Renal Advantage and Liberty Dialysis, which last month agreed to combine to form the third largest provider of dialysis services in the U.S., today announced that they have closed their deal.  The transaction – terms of which were not disclosed – was completed on December 17, 2010.  The combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.

"The completion of our deal signals a new era in the dialysis industry, uniting two patient-focused, physician driven and employee-oriented companies with great autonomy to build their brands," said Mark Caputo, founder of Liberty Dialysis and CEO of the combined organization.  "This transaction allows us to take advantage of the combined financial strength, purchasing power, and systems investment of two leaders in the industry."  

"As we begin a new year with change on the health care horizon, we are well positioned for robust growth in the future through this deal," said Michael D. Klein, who has served as chief executive officer of RAI. "By focusing on the patient, partnering with talented nephrologists, and recruiting the best caregivers, we will optimize patient outcomes through active participation of both patients and caregivers."

Liberty Dialysis has been among the fastest growing dialysis companies for each of the last eight years, achieving 25 percent annual growth rates.  Similarly, RAI has nearly doubled in size since its inception over five years ago.  To accommodate its rapid growth, RAI has moved into a new 54,000 square foot office building in the McEwen Building in Franklin, Tenn., a suburb of Nashville.  RAI will consolidate its existing corporate offices into this one location, improving efficiency while providing for its growth needs for the future. Liberty's existing administrative offices in conjunction with RAI's a
'/>"/>

SOURCE Renal Advantage
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC)
2. The Renal Anemia Market Shows Signs of Stabilization but Changes are Occurring in the Bone and Mineral Metabolism Market
3. Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures
4. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
5. Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today
6. New Report by BioTrends Examines the Treatment of Renal Anemia in China
7. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
8. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
9. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
10. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
11. Genomic Health Announces Results From the Largest Genomic Analysis of Localized Clear Cell Renal Carcinoma at American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...  Aptuit LLC announces that Aptuit SSCI, located ... has enhanced its capabilities in the areas of ... molecules, including biologic drugs, metabolites, and polymers, through ... spectrometer. In making the announcement, Dr. ... expanded large molecule capability enhances our early development ...
(Date:8/21/2014)... , Aug. 21, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic cancers and women,s health, has appointed ... and Managed Markets. Ms. Bauzon has a ... expanding payer coverage for laboratory services companies. She has ... with PerkinElmer, Inc., where she held the position of ...
(Date:8/21/2014)... , Aug. 21, 2014  eRelevance Corporation ( ... announced today that it has completed integration with ... for Plastic Surgery and Dermatology practices. ... value to healthcare practices using Nextech," stated ... Corporation. "Using information from the EMR we are ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
... The Center for,Translational Molecular Medicine (CTMM) - ... development of new techniques for,the diagnosis and treatment ... will receive research funding amounting to a total ... broad spectrum of small and,medium-sized enterprises, major industry ...
... March 31 CV Therapeutics, Inc.,(Nasdaq: CVTX ... the,American College of Cardiology 57th Annual Scientific Session ... in pancreatic islets isolated from animals and humans., ... GSIS seen with ranolazine may,contribute to the statistically ...
Cached Medicine Technology:Dutch Top Institute Allocates 150 Million Euro to R&D Projects Targeting Early Diagnosis and Treatment of Disease 2New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion 2New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion 3
(Date:8/22/2014)... 2014 Natural Clear Vision , a ... his own vision from legally blind to perfect 20/20 vision ... review. , “There is a huge portion of the ... function, and most people just think that’s the way it ... that can be pretty risky at times,” reports Michaels. “This ...
(Date:8/22/2014)... Epidermal growth factor receptor (EGFR) mutations found in ... of advanced non-small cell lung cancer (NSCLC) patients correlates ... DNA. , EGFR tyrosine kinase inhibitor (TKI) therapy is ... NSCLC, but the standard for determining mutation status is ... be limited or not available. A more abundant and ...
(Date:8/22/2014)... York, New York (PRWEB) August 22, 2014 ... continue to be filed in U.S. courts on ... events due to their use of prescription low ... court documents, a new claim was filed against ... man who allegedly suffered life-threatening heart issues due ...
(Date:8/22/2014)... 2014 (HealthDay News) -- An intensive effort to sterilize feral ... shelter in Florida and euthanized, a new study reveals. ... slow their intake into animal control," Dr. Julie Levy, a ... of Veterinary Medicine, said in a university news release. ... a big impact," she explained, "so we wanted to pick ...
(Date:8/22/2014)... Renal artery stenting to open blockages in the ... been excluded from modern clinical trials, according to ... Catheterization and Cardiovascular Interventions today by ... , University Hospitals Case Medical Center,s Sahil Parikh, ... of Medicine, Case Western Reserve University School of ...
Breaking Medicine News(10 mins):Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Neutering Project Curbed Feral Cat Population 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 2Health News:UH Case Medical Center's Dr. Parikh authors SCAI paper on renal artery stenosis treatment 3
... European Respiratory Society (ERS) and the European Centre for ... European Union Standards for Tuberculosis Care (ESTC). The 21 ... workers to ensure optimal diagnosis, treatment and prevention of ... TB cases in the EU/EEA in 2010 clearly showing ...
... cancer had limited side effects and in many cases ... a small-molecule oral drug, according to phase I data ... March 31 - April 4. Castration-resistant prostate cancer ... occurs when the disease progresses after treatment with androgen ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, March ... two hours more in labor during childbirth than women did ... authors said several factors helped to explain the longer labors. ... ratio of weight to height) accounted for a part of ...
... FRIDAY, March 30 (HealthDay News) -- People who have ... more likely to use hospital emergency departments, a new ... is an important indicator of access to care. People ... emergency departments for medical care, said Dr. Adit Ginde, ...
... than did women 50 years ago, according to an analysis ... Institutes of Health. The researchers could not identify all of ... the change is likely due to changes in delivery room ... determine whether modern delivery practices are contributing to the increase ...
... March 30 (HealthDay News) -- The declining number of ... is cause for concern because there,s already a shortage ... has occurred for the past six years, according to ... need to provide more information and training to medical ...
Cached Medicine News:Health News:Towards TB elimination: ECDC and ERS introduce new guidelines on tuberculosis care in Europe 2Health News:Early clinical data show galeterone safe, effective against prostate cancer 2Health News:U.S. Women in Labor Longer Than They Were 50 Years Ago 2Health News:Changes in Insurance Make ER Visits More Likely: Study 2Health News:NIH study finds women spend longer in labor now than 50 years ago 2Health News:NIH study finds women spend longer in labor now than 50 years ago 3Health News:Fewer U.S. Med Students Choose Psychiatry: Report 2
Cannulated Interference Screws...
... Endoscopy Components, LLC offers ... Equipment "Made in Germany". ... manufactured according to ISO ... most excellent design elements ...
... provide excellent protection and ease of use. ... closer to an adhesive in molecular weight ... to maintain viscosity at high shear rates, ... for superb performance during capsulorhexis, phaco, IOL ...
... moisturizing mist for the eyes developed with ... from Oregon Health Sciences University's Casey Eye ... (2000) and dry eye patients showed, on ... volume of the eyes' tear film without ...
Medicine Products: